Zhejiang Jianye Chemical Co., Ltd. (SHA:603948)
China · Delayed Price · Currency is CNY 27.88
+0.26 (0.94%)
Apr 29, 2026, 1:24 PM CST
Zhejiang Jianye Chemical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 2,049 | 2,057 | 2,296 | 2,561 | 2,707 | 2,723 |
Other Revenue | - | - | 98.57 | 88.64 | 89.14 | 76.4 |
| 2,049 | 2,057 | 2,394 | 2,650 | 2,796 | 2,799 | |
Revenue Growth (YoY) | -12.51% | -14.07% | -9.64% | -5.24% | -0.12% | 61.94% |
Cost of Revenue | 1,674 | 1,696 | 2,067 | 2,151 | 2,157 | 2,299 |
Gross Profit | 375.13 | 361.89 | 326.92 | 499.01 | 638.57 | 500.03 |
Selling, General & Admin | 69.83 | 70.7 | 79.02 | 93.2 | 104.89 | 86.17 |
Research & Development | 41.3 | 31.33 | 31.18 | 36.52 | 97.63 | 96.21 |
Other Operating Expenses | -6.78 | -6.97 | -17.09 | 8.05 | 14.33 | 6.86 |
Operating Expenses | 104.35 | 95.07 | 90.74 | 140.69 | 216.24 | 190.95 |
Operating Income | 270.77 | 266.82 | 236.18 | 358.33 | 422.33 | 309.08 |
Interest Expense | - | - | -0.07 | -0.08 | -0.07 | -0.05 |
Interest & Investment Income | 8.85 | 7.87 | 11.62 | 17.92 | 16.42 | 12.73 |
Currency Exchange Gain (Loss) | - | - | 1.95 | 1.39 | 5.01 | -2.67 |
Other Non Operating Income (Expenses) | 26.4 | 26.56 | -0.32 | -0.37 | -0.42 | -0.6 |
EBT Excluding Unusual Items | 306.02 | 301.25 | 249.37 | 377.19 | 443.26 | 318.49 |
Impairment of Goodwill | - | - | -0.72 | -0.38 | -0.38 | -0.35 |
Gain (Loss) on Sale of Assets | 3.53 | 3.46 | 0.54 | -1.95 | -0.13 | 0.08 |
Asset Writedown | -17.88 | -17.78 | -5.2 | - | - | -2.58 |
Other Unusual Items | - | - | 7.97 | 11.01 | 11.95 | 13.9 |
Pretax Income | 291.67 | 286.92 | 251.95 | 385.88 | 454.7 | 329.53 |
Income Tax Expense | 58.4 | 56.96 | 42.9 | 68.19 | 64.45 | 39.51 |
Net Income | 233.27 | 229.96 | 209.06 | 317.68 | 390.24 | 290.02 |
Net Income to Common | 233.27 | 229.96 | 209.06 | 317.68 | 390.24 | 290.02 |
Net Income Growth | 16.73% | 10.00% | -34.19% | -18.59% | 34.56% | 130.75% |
Shares Outstanding (Basic) | 162 | 162 | 162 | 160 | 160 | 160 |
Shares Outstanding (Diluted) | 162 | 162 | 162 | 160 | 160 | 160 |
Shares Change (YoY) | 0.51% | -0.07% | 1.01% | 0.32% | -0.19% | 4.54% |
EPS (Basic) | 1.44 | 1.42 | 1.29 | 1.98 | 2.44 | 1.81 |
EPS (Diluted) | 1.44 | 1.42 | 1.29 | 1.98 | 2.44 | 1.81 |
EPS Growth | 16.15% | 10.08% | -34.85% | -18.85% | 34.81% | 120.73% |
Free Cash Flow | 400.99 | 373.66 | 260.71 | 283.88 | 329.3 | 88.96 |
Free Cash Flow Per Share | 2.48 | 2.31 | 1.61 | 1.77 | 2.06 | 0.56 |
Dividend Per Share | - | - | 1.000 | 1.000 | 1.920 | 0.550 |
Dividend Growth | - | - | - | -47.92% | 249.09% | 22.22% |
Gross Margin | 18.30% | 17.59% | 13.65% | 18.83% | 22.84% | 17.86% |
Operating Margin | 13.21% | 12.97% | 9.87% | 13.52% | 15.10% | 11.04% |
Profit Margin | 11.38% | 11.18% | 8.73% | 11.99% | 13.96% | 10.36% |
Free Cash Flow Margin | 19.56% | 18.16% | 10.89% | 10.71% | 11.78% | 3.18% |
EBITDA | 350.37 | 344.27 | 305.02 | 432.18 | 496.17 | 367.66 |
EBITDA Margin | 17.10% | 16.73% | 12.74% | 16.31% | 17.75% | 13.13% |
D&A For EBITDA | 79.6 | 77.44 | 68.83 | 73.85 | 73.84 | 58.57 |
EBIT | 270.77 | 266.82 | 236.18 | 358.33 | 422.33 | 309.08 |
EBIT Margin | 13.21% | 12.97% | 9.87% | 13.52% | 15.10% | 11.04% |
Effective Tax Rate | 20.02% | 19.85% | 17.03% | 17.67% | 14.17% | 11.99% |
Revenue as Reported | - | - | 2,394 | 2,650 | 2,796 | 2,799 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.